DEF: Corteva Reports Strong 2025 Performance, Board Refreshment
Proxy Statement
Corteva, Inc. announces solid 2025 financial results, significant shareholder returns, and proposes a refreshed board slate for its upcoming April 28, 2026 Annual Stockholder Meeting.
Summary
- Corteva delivered solid performance in 2025, expanding earnings and margins through technology penetration, customer delivery, and productivity.
- The company returned over $1.5 billion to stockholders in 2025 via dividends and share repurchases, while also investing in research and development and early-stage disruptive technologies.
- Enlist™ E3 soybeans remained the number one soybean technology in the United States, and the seed segment expanded its corn and soybean licensing income.
- The crop protection segment experienced volume gains across the portfolio, led by double-digit volume growth in biologicals and strong demand for new products.
- A proposed separation is underway, leading to board refreshment with two new nominees, Jean-Marc Gilson and Christopher J. Policinski, replacing retiring directors Lamberto Andreotti and Michael Johanns.
- Corteva engaged in constructive dialogue with stockholders representing approximately 48% of its outstanding common stock in 2025.
- The Annual Stockholder Meeting will be held virtually on April 28, 2026, at 8:00 a.m. Eastern Time, with an agenda including director elections, advisory votes on executive compensation, and ratification of PricewaterhouseCoopers LLP as the independent auditor.
- The 2025 enterprise Performance Reward Plan (PRP) had a payout factor of 190.0% of target, with the seed business unit PRP at 186.8% and the crop protection business unit PRP at 179.3%.
- The 2023-2025 Annual PSU Awards resulted in an overall payout of 57.3% of target, with Operating EPS Growth performance at zero payout.
- The Growth Incentive Plan for 2024 had a payout factor of 0% and will not be continued in 2025.
- For 2026, the short-term incentive program will be simplified to a single enterprise PRP, focusing on Operating EBITDA (75%) and Operating EBITDA Margin (25%), eliminating the Free Cash Flow metric.
- The 2026 long-term incentive program will eliminate stock options, shifting to 50% PSUs and 50% RSUs for executive compensation.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a strong positive filing, highlighting robust financial performance, significant shareholder returns, and strategic investments in innovation and sustainability. While long-term EPS growth for 2023-2025 PSUs was below target, the overall 2025 results and future strategic adjustments are encouraging.
Positives
- Delivered solid performance in 2025, expanding earnings and margins through technology penetration, customer delivery, and productivity.
- Returned over $1.5 billion to stockholders in 2025 via dividends and share repurchases.
- Made significant investments in research and development and early-stage disruptive technologies for long-term value creation.
- Technologically advantaged products contributed significantly to margin growth in 2025.
- Enlist™ E3 soybeans remained the number one soybean technology in the United States and the segment expanded its corn and soybean licensing income.
- Crop protection segment experienced volume gains across the portfolio, led by double-digit volume growth in biologicals and strong demand for new products.
- Execution on business and operational strategy, as well as ongoing productivity initiatives, optimized resource allocation.
- Produced approximately 300 new seed hybrids and varieties and received over 200 registration approvals for crop protection products spanning nearly 40 active ingredients in 2025.
- 100% of seed and crop protection technology pipelines align with Corteva's sustainability innovation goal.
- Achieved continued Operating EBITDA Margin growth, reflecting the ability to capture value for its technology.
- Management contributed over a $650 million improvement in cost of sales.
- The 2025 enterprise Performance Reward Plan (PRP) had a strong payout factor of 190.0% of target.
- Received approximately 89% stockholder support for the say-on-pay proposal in the previous year.
- Named one of the top decile companies in Wharton's Zicklin Center for Political Accountability's CPA-Zicklin Index for high transparency in political activities.
- Maintains strong corporate governance practices, including 92% independent board, annual board elections, majority voting, independent executive sessions, and director evaluations.
- All non-employee directors are in compliance with stock ownership guidelines or are anticipated to reach them within the prescribed timeframe.
Negatives
- The crop protection segment experienced competitive pressures.
- The 2023-2025 Annual PSU Awards resulted in an overall payout of 57.3% of target, with Operating EPS Growth performance resulting in a payout factor of zero, indicating underperformance against this specific long-term goal.
- The Growth Incentive Plan for 2024 had a payout factor of 0%, failing to meet stretch Operating EBITDA goals.
- One director, Mr. Lutz, did not attend the Company's 2025 Annual Meeting of Stockholders.
Risks
- Failure to obtain or maintain necessary regulatory approvals for some products.
- Failure to successfully develop and commercialize the company's pipeline.
- Effect of the degree of public understanding and acceptance or perceived public acceptance of the company's biotechnology and other agricultural products.
- Failure to comply with competition and antitrust laws.
- Effect of changes in agricultural and related policies of governments and international organizations.
- Costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements.
- Effect of climate change and unpredictable seasonal and weather factors.
- Effect of competition in the company's industry.
- Competitors establishment of an intermediary platform for distribution of the company's products.
- Risks related to recent funding and staff reductions at U.S. government agencies.
- Risk related to geopolitical and military conflict.
- Effect of volatility in the company's input costs.
- Risks related to the company's global operations.
- Effect of industrial espionage and other disruptions to the company's supply chain, information technology or network systems.
- Risks related to environmental litigation and the indemnification obligations of legacy EIDP liabilities in connection with the Corteva Separation.
- Impact of the company's dependence on third parties with respect to certain of its raw materials or licenses and commercialization.
- Failure of the company's customers to pay their debts to the company, including customer financing programs.
- Failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions.
- Failure to raise capital through the capital markets or short-term borrowings on terms acceptable to the company.
- Increases in pension and other post-employment benefit plan funding obligations.
- Risks related to pandemics or epidemics.
- Capital markets sentiment towards sustainability matters.
- The company's intellectual property rights or defense against intellectual property claims asserted by others.
- Effect of counterfeit products.
- The company's dependence on intellectual property cross-license agreements.
- Risks related to Corteva's separation from DowDuPont.
- Risks related to Corteva's proposed separation, including whether the objectives of the proposed separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the proposed separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the proposed separation could divert the attention and time of the company's management; the risk of any unexpected costs or expenses resulting from the proposed separation process or separation itself; and the risk of any litigation as a result of, or relating to, the proposed separation.
- Other unidentified risks or risks not currently expected to have a material impact on the business.
Future Outlook
Corteva anticipates continued long-term value creation for stockholders through ongoing investment in research and development and early-stage disruptive technologies. The company is committed to strengthening the sustainability of its portfolio, with 100% of its seed and crop protection technology pipelines aligning to sustainability innovation goals. A proposed separation is underway, which will lead to the formation of two independent public company boards. For 2026, the short-term incentive program will be simplified to a single enterprise PRP, focusing on Operating EBITDA and Operating EBITDA Margin, and the long-term incentive program will shift to 50% PSUs and 50% RSUs, eliminating stock options, to enhance executive retention and align with long-term stockholder interests.
Management Comments
- Our teams delivered solid performance in technology penetration, customer delivery and productivity that allowed us to continue to expand our earnings and margins.
- Given our strong results for the full year 2025, we returned more than $1.5 billion to stockholders during the year via dividends and share repurchases, while also investing in research and development and early-state disruptive technologies that will drive long-term value creation for our stockholders in the years to come.
- As an agriculture technology company, our innovation on behalf of customers and our commitment to their productivity is the foundation of our ability to deliver long-term value for our stockholders and help sustain the planet by providing leading technology that support sustainable food and energy supplies.
- Our technologically advantaged products contributed significantly to our margin growth in 2025.
- In seed, Enlist™ E3 soybeans remained the number one soybean technology in the United States and the segment expanded its corn and soybean licensing income.
- In crop protection, we experienced volume gains across the portfolio, led by double-digit volume growth in biologicals and strong demand for new products.
- The execution on our business and operational strategy, as well as ongoing productivity initiatives, continue to allow us to optimize our resource allocation, including returns to stockholders, as well as investment in our research capabilities and disruptive technologies, to drive the long-term value creation for our stockholders and customers.
- We believe it is essential to engage with all our stakeholders to assure that a mix of perspectives helps guide our value creation strategy.
- Corteva believes that it is our responsibility to create a sustainable business for our stockholders, as well as for farmers so they can deliver on the words needs for food, energy and clothing.
Industry Context
StockSavvy.ai notes that Corteva's strong performance in 2025, particularly in seed technology (Enlist™ E3 soybeans) and biologicals within crop protection, demonstrates its ability to innovate and capture value in a competitive agriculture technology market. The continued focus on R&D and sustainable innovation aligns with broader industry trends emphasizing environmental responsibility and efficiency in food production. The proposed separation suggests a strategic move to potentially unlock further value by creating more focused entities, a common trend among diversified conglomerates seeking to optimize operations and investor appeal.
Comparison to Industry Standards
- Corteva's 2025 enterprise PRP payout factor of 190.0% of target, and business unit payouts (Seed 186.8%, Crop Protection 179.3%), indicate strong performance relative to internal targets, suggesting outperformance against its own benchmarks.
- The company's Operating EBITDA Margin of 22.1% in 2025, exceeding its 21.0% target, positions it favorably in terms of profitability within the specialty chemicals and agriculture sectors, where margin expansion is a key indicator of competitive advantage and pricing power.
- The 2023-2025 PSU payout of 57.3% of target, driven by a zero payout for Operating EPS Growth despite a 114.6% payout for RONA, suggests mixed long-term performance against specific metrics. This indicates challenges in achieving aggressive EPS growth targets over the three-year period, potentially lagging some high-growth industry peers in that specific metric.
- The company's commitment to sustainability, with 100% of its technology pipelines aligning to sustainability goals, is a strong indicator of alignment with evolving global benchmarks and investor expectations for ESG performance, potentially positioning it ahead of some competitors less focused on integrated sustainability.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Lamberto Andreotti | April 28, 2026 | Retirement | |
| Director | Michael Johanns | April 28, 2026 | Retirement | |
| Director Nominee | Jean-Marc Gilson | Upon election at Annual Meeting | Board refreshment in preparation for proposed separation | |
| Director Nominee | Christopher J. Policinski | Upon election at Annual Meeting | Board refreshment in preparation for proposed separation | |
| Director | Rebecca B. Liebert, Ph.D. | February 28, 2025 | To pursue other professional opportunities | |
| Chair of Sustainability and Innovation Committee | Klaus A. Engel, Ph.D. | March 1, 2025 | Appointment following Dr. Liebert's retirement | |
| Audit Committee Member | Klaus A. Engel, Ph.D. | Michael O. Johanns | March 1, 2025 | Committee rotation |
| Chair of People and Compensation Committee | Lamberto Andreotti | Kerry J. Preete | May 1, 2025 | Committee rotation |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | Proposed election of 12 directors, including two new nominees (Jean-Marc Gilson and Christopher J. Policinski) replacing two retiring directors (Lamberto Andreotti and Michael Johanns). | April 28, 2026 | Enhances board expertise and diversity in preparation for the proposed company separation, ensuring a mix of skills and perspectives. |
| Board Diversity and Inclusion | Commitment to inclusion and support for board candidates from underrepresented communities and socioeconomic backgrounds, with steps taken to identify diverse candidates. | Ongoing | Aims to foster a board representative of global operations and diverse backgrounds, enhancing decision-making and oversight. |
| Committee Chair Rotation | Expectation to rotate committee chairs every 5 years, with the incoming chair serving on the committee for a minimum of one year prior to appointment. | Ongoing | Ensures fresh perspectives and leadership within committees, promoting effective governance and oversight. |
| Board Evaluation Process | Annual self-evaluation of the Board, committees, and individual directors, with an independent third-party evaluation every three years (postponed for 2025 due to proposed separation). | Ongoing | Maintains accountability and effectiveness of the Board and its committees, though the postponement of the third-party review for 2025 is a temporary deviation. |
| Director Stock Ownership Guidelines | Non-employee directors are required to own five times their annual cash retainer in equity within five years of appointment and hold all equity-based compensation until the guideline is met. | Ongoing | Aligns directors' financial interests with those of stockholders, promoting long-term value creation. |
| Executive Compensation Program Design | Simplification of the 2026 short-term incentive program to a single enterprise PRP, eliminating the Free Cash Flow metric, and shifting the long-term incentive program to 50% PSUs and 50% RSUs, eliminating stock options. | 2026 | Aims to drive whole company performance, enhance executive retention, and better align compensation with long-term stockholder interests, particularly in light of the proposed separation. |
| Compensation Recovery Policy (Clawback) | Maintains a compensation recovery policy complying with NYSE Listing Rules and Section 10D, covering incentive-based compensation for officers subject to Section 16 of the Exchange Act. | Ongoing | Strengthens accountability and discourages misconduct by allowing for the recovery of incentive-based compensation in cases of accounting restatements or specified misconduct. |
| Prohibition on Hedging and Pledging | Insider trading policy prohibits directors and executive officers from engaging in hedging transactions, short sales, holding securities in margin accounts, or pledging securities. | Ongoing | Ensures alignment of interests between executives/directors and stockholders by preventing activities that could decouple personal financial interests from company performance. |
Legal Proceedings
- Risks related to environmental litigation and the indemnification obligations of legacy EIDP liabilities in connection with the Corteva Separation are mentioned as a forward-looking risk.
Related Party Transactions
- The Board adopted written policies and procedures for approving or ratifying Related Person Transactions exceeding $120,000, but no specific related party transactions were disclosed as having occurred in 2025.
Stakeholder Impact
- Shareholders: Significant returns of over $1.5 billion via dividends and share repurchases, focus on long-term value creation, strong say-on-pay support, board refreshment, and proposed separation to potentially unlock value.
- Employees: Commitment to attracting, retaining, and developing workforce, professional development, inclusion and belonging initiatives, competitive total rewards, and prioritizing safety and wellness.
- Customers: Innovation on behalf of customers, commitment to productivity, provision of leading technology for sustainable food and energy supplies, and development of new products like Enlist™ E3 soybeans and biologicals.
- Suppliers: Expectation to adhere to Corteva's values and Supplier Code of Conduct, ensuring fair wages, non-discrimination, human rights, ethical procurement, and prohibition of child/forced labor.
- Creditors: Disciplined capital allocation, reliable earnings, and margin expansion contribute to the company's financial stability.
- Planet/Environment: Focus on sustainable agricultural innovation, biodiversity, climate strategies and targets, development of environmentally conscious products, and transparent sustainability impact reporting.
Next Steps
- Hold the Annual Stockholder Meeting on April 28, 2026, to vote on director elections, executive compensation, frequency of executive compensation vote, and ratification of the independent auditor.
- Continue with the proposed separation of the company, including ongoing evaluation of candidates for two independent public company boards.
- Publish the 2025 Impact Report, expected in early April 2026.
- Implement the simplified 2026 enterprise Performance Reward Plan (PRP) with Operating EBITDA and Operating EBITDA Margin as key metrics.
- Implement the 2026 long-term incentive program, shifting to 50% PSUs and 50% RSUs and eliminating stock options.
Key Dates
| Date | Description |
|---|---|
| February 28, 2025 | Rebecca B. Liebert, Ph.D. retired from the Board. |
| March 1, 2025 | Dr. Engel became Chair of the Sustainability and Innovation Committee, and Mr. Johanns replaced Dr. Engel on the Audit Committee. |
| May 1, 2025 | Mr. Preete replaced Mr. Andreotti as the Chair of the People and Compensation Committee. |
| July 2025 | Corteva's peer group was revised to remove Avery Dennison Corporation and FMC Corporation, and add Becton, Dickinson and Co. and Biogen Inc. |
| September 30, 2025 | State Street Corporation's beneficial ownership reported. |
| December 31, 2025 | End of fiscal year for 2025 performance and median employee determination date for CEO pay ratio. |
| January 1, 2026 | Charles V. Magro named chair of the board of directors of CropLife International. |
| January 2026 | Final payout determination for 2023-2025 PSU awards. |
| March 2, 2026 | Beneficial ownership of Corteva's common stock reported as of this date. |
| March 9, 2026 | Record date for determining stockholders entitled to receive notice of the 2026 Meeting and to vote. |
| March 19, 2026 | Date of the Letter from Chairman and CEO, and Notice of the Annual Meeting of Stockholders. Proxy materials first distributed to stockholders. |
| April 2026 | Expected publication of Corteva's 2025 Impact Report. |
| April 24, 2026 | Cut-off date for voting instructions for shares held in employee savings plans (11:59 p.m. Eastern Time) and for submitting pre-meeting questions (11:59 p.m. Eastern Time). |
| April 27, 2026 | Cut-off date for voting instructions for all other shares (11:59 p.m. Eastern Time). |
| April 28, 2026 | Annual Stockholder Meeting date and time (8:00 a.m. Eastern Time). |
| November 19, 2026 | Deadline for stockholder proposals for the 2027 Meeting under Rule 14a-8. Also, the close of business start date for advance written notification for other annual meeting business for the 2027 Meeting. |
| December 19, 2026 | Close of business end date for advance written notification for other annual meeting business for the 2027 Meeting. |
| October 20, 2026 | Close of business start date for advance written notification to nominate a director through proxy access for the 2027 Meeting. |
| February 27, 2027 | Deadline for stockholders to provide notice for soliciting proxies in support of director nominees under universal proxy rules. |
| 2027 | Next Annual Meeting of Stockholders, where the next say-on-pay advisory vote will occur. |
Recommendation
strong buyCorteva's 2025 performance demonstrates robust financial health, exceeding key targets for Operating EBITDA, Operating EBITDA Margin, and Free Cash Flow. The significant return of over $1.5 billion to shareholders through dividends and share repurchases, coupled with strategic investments in R&D and sustainable innovation, signals strong management and a commitment to long-term value creation. While the 2023-2025 PSU payout was mixed due to lower EPS growth, the company's core business segments are performing exceptionally well, particularly in seed technology and biologicals. The proposed separation and upcoming changes to the incentive structure for 2026 are strategic moves to further optimize performance and align with shareholder interests. The company's strong governance and transparency further bolster confidence. These factors collectively suggest a positive outlook and strong potential for continued growth and shareholder returns.
Keywords
Corteva, Agriculture Technology, SEC Filing, Proxy Statement, Financial Performance, Shareholder Returns, Dividends, Share Repurchases, R&D Investment, Innovation, Enlist E3 Soybeans, Crop Protection, Biologicals, Operating EBITDA, Operating EBITDA Margin, Free Cash Flow, Executive Compensation, Corporate Governance, Board of Directors, Director Nominees, Sustainability, Risk Management, Proposed Separation, Annual Meeting, PricewaterhouseCoopers, Stock Ownership Guidelines, Long-Term Incentives, PSUs, RSUs, Stock Options, RONA, Operating EPS Growth
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.